|
Nath Bio-Genes (India) Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
436.46 Cr.
|
P/BV
|
0.68
|
Book Value (Rs.)
|
336.91
|
|
52 Week High/Low (Rs.)
|
256/138
|
FV/ML
|
10/1
|
P/E(X)
|
11.31
|
|
Bookclosure
|
17/08/2024
|
EPS (Rs.)
|
20.31
|
Div Yield (%)
|
0.87
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 40.58 | 41.56 | 36.16 | -63.43 | 12.30 |
| | | | | | |
| Net CashFlow From Operating Activities | 17.58 | 74.59 | 38.37 | 17.05 | 14.21 |
| Net Cash Used In Investing Activities | -3.96 | -27.40 | -2.88 | -19.85 | -20.77 |
| Net Cash Used From Financing Activities | -2.13 | -7.78 | -1.67 | -22.23 | 5.74 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 11.49 | 39.41 | 33.81 | -25.04 | -0.81 |
| Cash And Cash Equivalents Begin of Year | 77.41 | 38.00 | 4.18 | 29.22 | 3.29 |
| Cash And Cash Equivalents End Of Year | 88.90 | 77.41 | 38.00 | 4.18 | 2.48 |
